Gainers Tenon Medical (NASDAQ:TNON) shares moved upwards by 70.3% to $9.28 during Tuesday's aft

Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's

LEXINGTON, Mass., Aug. 13, 2026 /PRNewswire/ -- Curis, Inc. (Nasdaq: CRIS), a biotechnology company

Gainers ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market

Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regul

LEXINGTON, Mass., July 30, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company

On Wednesday, Curis Inc. (NASDAQ:CRIS) announced updated positive clinical trial results for its inv

Curis gained attention after positive emavusertib data as analyst raised its price target to $43 and

HC Wainwright & Co. analyst Sara Nik maintains Curis (NASDAQ:CRIS) with a Buy and raises the

Curis, Inc. (CRIS) Discusses Positive Data From Emavusertib Combination Study in Primary CNS Lymphom

Curis Inc. (NASDAQ:CRIS) on Wednesday announced updated positive clinical trial results for its inve

Curis shares positive updated clinical data for emavusertib and increases its year-end guidance for

Gainers InMed Pharmaceuticals (NASDAQ:INM) stock moved upwards by 66.8% to $2.57 during Wednesday&#

Updated Clinical Data in PCNSL Increased Guidance on Year-End Data in CLL Company to Host Webcast at

Gainers: Q32 Bio up 29.6%, Mint up 75.8%, Fast Track up 58.2%, eLong up 33.4%, Sobr Safe up 29.2%, E

On June 26, 2026, Curis announced that eleven clinical sites had opened for enrollment in the TakeAi

LEXINGTON, Mass., July 6, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company f

Curis, Inc. shares surged 8.51% after the bell after the company confirmed its approved reverse stoc

Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T

Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular se

Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announ

Gainers INVO Fertility (NASDAQ:IVF) shares moved upwards by 67.3% to $2.08 during Friday's regu

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance

Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-494

Eleven sites open for patient enrollment in TakeAim CLL combination study with zanubrutinib; Company

Gainers Atlantic International (NASDAQ:ATLN) shares increased by 41.0% to $1.1 during Thursday'

Curis, Inc. (CRIS) Q1 2026 Earnings Call Transcript

Curis (NASDAQ:CRIS) reported quarterly losses of $(1.25) per share which missed the analyst consensu

Curis (NASDAQ:CRIS) reported quarterly losses of $(1.25) per share which missed the analyst consensu

Management to host conference call today at 4:30 p.m. ET LEXINGTON, Mass.

LEXINGTON, Mass., May 5, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company fo

Kiniksa Pharmaceuticals International, plc (KNSA) came out with quarterly earnings of $0.27 per shar

Curis (CRIS) might move higher on growing optimism about its earnings prospects, which is reflected

Curis, Inc. (CRIS) Q4 2025 Earnings Call Transcript

Management to host conference call today at 4:30 p.m. ET LEXINGTON, Mass.

INGOLSTADT, Germany--(BUSINESS WIRE)--SecurityBridge, a leading provider of cybersecurity solutions

LEXINGTON, Mass., March 12, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company

eXoZymes (NASDAQ: EXOZ - Get Free Report) and Curis (NASDAQ: CRIS - Get Free Report) are both small-

Led by Nantahala Capital, Stonepine Capital Management, Pointillist Partners, LLC, and The Red Hook